These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 791322)

  • 1. The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man.
    Faber OK; Mouridsen HT; Skovsted L
    Br J Clin Pharmacol; 1975 Jun; 2(3):281-5. PubMed ID: 791322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of cyclophosphamide in man following treatment with methotrexate.
    Mouridsen HT; Jacobsen E; Faber O
    Acta Pharmacol Toxicol (Copenh); 1976 May; 38(5):508-12. PubMed ID: 989253
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of cyclophosphamide in renal failure.
    Mouridsen HT; Jacobsen E
    Acta Pharmacol Toxicol (Copenh); 1975; 36(Suppl 5):409-14. PubMed ID: 1173530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of cyclophosphamide in man after treatment with allopurinol.
    Witten J; Frederiksen PL; Mouridsen HT
    Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):392-4. PubMed ID: 7376891
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulphaphenazole and drug oxidation in man.
    Back DB; Park BK; Tjia JF; Newby SN
    Br J Clin Pharmacol; 1983 Oct; 16(4):460-1. PubMed ID: 6626444
    [No Abstract]   [Full Text] [Related]  

  • 6. The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.
    Mouridsen HT; Faber O; Skovsted L
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):98-106. PubMed ID: 4479366
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of cyclophosphamide in man.
    Cohen JL; Jao JY; Jusko WJ
    Br J Pharmacol; 1971 Nov; 43(3):677-80. PubMed ID: 5157730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of damaged liver parenchyma, renal insufficiency and hemodialysis on the pharmacokinetics of cyclophosphamide and its activated metabolites].
    Wagner T; Heydrich D; Bartels H; Hohorst HJ
    Arzneimittelforschung; 1980; 30(9):1588-92. PubMed ID: 7193030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chloramphenicol on the metabolism and lethality of cyclophosphamide (Cytoxan).
    Dixon RL
    Proc West Pharmacol Soc; 1968; 11():23-4. PubMed ID: 5734478
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of chloramphenicol on the metabolism and lethality of cyclophosphamide in rats.
    Dixon RL
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1151-5. PubMed ID: 5655657
    [No Abstract]   [Full Text] [Related]  

  • 11. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9.
    Baldwin SJ; Bloomer JC; Smith GJ; Ayrton AD; Clarke SE; Chenery RJ
    Xenobiotica; 1995 Mar; 25(3):261-70. PubMed ID: 7618352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biotransformation of cyclophosphamide in man: influence of prednisone.
    Faber OK; Mouridsen HT; Skovsted L
    Acta Pharmacol Toxicol (Copenh); 1974 Sep; 35(3):195-200. PubMed ID: 4479295
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of starvation and chloramphenicol on acceleration of bacterial dihexyl sulfosuccinate biotransformation.
    Chmelárová Z; Závadská I; Húska J; Tóth D
    Folia Microbiol (Praha); 2000; 45(6):493-5. PubMed ID: 11501413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline blood flow and bradykinin-induced vasodilator responses in the human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulphaphenazole.
    Passauer J; Büssemaker E; Lässig G; Pistrosch F; Fauler J; Gross P; Fleming I
    Clin Sci (Lond); 2003 Oct; 105(4):513-8. PubMed ID: 12826020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the correlation between rate of biotransformation and haematological toxicity of cyclophosphamide.
    Mouridsen HT; Witten J; Frederiksen PL; Hulsbaek I
    Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):328-30. PubMed ID: 716950
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of chloramphenicol on the toxic and therapeutic actions of cyclophosphane].
    Bogush TA
    Antibiot Med Biotekhnol; 1986 Mar; 31(3):199-202. PubMed ID: 3717919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of chloramphenicol on biotransformation reactions].
    Huyen HT; Müller D; Lübbe H; Klinger W
    Arch Int Pharmacodyn Ther; 1974 Oct; 211(2):269-79. PubMed ID: 4460918
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of drug metabolism by chloramphenicol.
    Christensen LK; Skovsted L
    Lancet; 1969 Dec; 2(7635):1397-9. PubMed ID: 4188280
    [No Abstract]   [Full Text] [Related]  

  • 19. Phenobarbital effects on cyclophosphamide pharmacokinetics in man.
    Jao JY; Jusko WJ; Cohen JL
    Cancer Res; 1972 Dec; 32(12):2761-4. PubMed ID: 4678592
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.